New ovarian cancer study to probe causes of PARP inhibitor resistance
4 April 2022
![Professor David Williams](/womens-health/sites/womens_health/files/styles/large_image/public/david_williams_0.png?itok=y7XQfbl8)
Professor David Williams (UCL EGA Institute for Womens Health) said that a new study by Glasgow University has “exciting implications for clinical practice, paving the way for better management of advanced ovarian cancer through more personalised targeted care.”
Read: